Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-103620
Filing Date
2009-05-07
Accepted
2009-05-07 17:30:06
Documents
1
Effectiveness Date
2009-05-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddfan14a.htm DFAN14A 15027
  Complete submission text file 0001193125-09-103620.txt   17000
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-19700 | Film No.: 09806880
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901
Business Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901 4154481200
EASTBOURNE CAPITAL MANAGEMENT LLC/CA (Filed by) CIK: 0001140888 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DFAN14A